SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-21-044732
Filing Date
2021-03-31
Accepted
2021-03-31 16:06:13
Documents
74
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm211758d1_10k.htm 10-K 923449
2 EXHIBIT 23.1 tm211758d1_ex23-1.htm EX-23.1 3243
3 EXHIBIT 31.1 tm211758d1_ex31-1.htm EX-31.1 10654
4 EXHIBIT 32.1 tm211758d1_ex32-1.htm EX-32.1 5806
  Complete submission text file 0001104659-21-044732.txt   7325678

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ttnp-20201231.xml EX-101.INS 1927266
6 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20201231.xsd EX-101.SCH 64062
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20201231_cal.xml EX-101.CAL 51418
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20201231_def.xml EX-101.DEF 254113
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20201231_lab.xml EX-101.LAB 450817
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20201231_pre.xml EX-101.PRE 431231
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13341 | Film No.: 21793303
SIC: 2836 Biological Products, (No Diagnostic Substances)